CSS
NDRM

Cubist Systematic Strategies’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Cubist Systematic Strategies’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,697
Closed -$650K – 2259
2017
Q3 		$650K Buy
+16,697
New +$614K 0.04% 658

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Cubist Systematic Strategies's NDRM Position: Q4 2017 in Review

Cubist Systematic Strategies sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 16,697 shares — an estimated $650K sold.

Cubist Systematic Strategies first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $650K in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Cubist Systematic Strategies reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Cubist Systematic Strategies sold 16,697 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $650K.
  • Cubist Systematic Strategies first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • Cubist Systematic Strategies's NeuroDerm Ltd. Ordinary Shares position peaked at $650K in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Cubist Systematic Strategies's 13F filing for Q4 2017, filed 14 Feb 2018.